Targeting homeobox genes in Acute Myeloid Leukaemia [ 2017 - 2019 ]

Research Grant

Researchers: Dr Benjamin Shields (Principal investigator) ,  A/Pr Matthew Mccormack

Brief description Acute myeloid leukaemia (AML) is a common blood cancer with dire clinical prognosis due to a lack of targeted molecular therapies. In this proposal we will identify new ways of targeting transcription factor proteins that are overexpressed in AML and promote leukaemia by repressing normal cellular growth controls. This may lead to novel methods to target leukaemic stem cells to specifically eliminate myeloid leukemia

Funding Amount $AUD 674,148.32

Funding Scheme Project Grants

Notes Standard Project Grant